Related references
Note: Only part of the references are listed.Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?
Marlies de Ligt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials
Yanxia Liu et al.
CLINICAL NUTRITION (2015)
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
Shihui Chen et al.
DIGESTIVE AND LIVER DISEASE (2015)
Effect of resveratrol on experimental non-alcoholic steatohepatitis
Sara Heeboll et al.
PHARMACOLOGICAL RESEARCH (2015)
The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children
K. Kazankov et al.
PEDIATRIC OBESITY (2015)
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Resveratrol Increases Bone Mineral Density and Bone Alkaline Phosphatase in Obese Men: A Randomized Placebo-Controlled Trial
Marie Juul Ornstrup et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
Miriam Mendez-del Villar et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits
Anwar Dudekula et al.
PLOS ONE (2014)
Resveratrol and cardiovascular health - Promising therapeutic or hopeless illusion?
Philip Chiu-Tsun Tang et al.
PHARMACOLOGICAL RESEARCH (2014)
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Sara Heeboll et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence
Ketan R. Patel et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
Jun Yoshino et al.
CELL METABOLISM (2012)
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
Pierre Bedossa et al.
HEPATOLOGY (2012)
Transcriptomic and Metabonomic Profiling Reveal Synergistic Effects of Quercetin and Resveratrol Supplementation in High Fat Diet Fed Mice
Mingmei Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Resveratrol - pills to replace a healthy diet?
Veronique S. Chachay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Resveratrol, sirtuins, and the promise of a DR mimetic
Joseph A. Baur
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis
Ayako Suzuki et al.
LIVER INTERNATIONAL (2006)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
